The Peripheral Stent Market is expected to register a CAGR of 6.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Product Type (Analgesics, Cold & Cough Medications, Digestive Health Products, Vitamins & Dietary Supplements, Topical Products, Others). The market is further segmented based on by Distribution Channel (Pharmacies & Drugstores, Supermarkets & Hypermarkets, Online Pharmacies, Convenience Stores). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Peripheral Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Peripheral Stent Market Segmentation
Product Type- Self-Expanding Stents
- Balloon-Expandable Stents
- Covered Stents
- Drug-Eluting Stents
- Bioresorbable Stents
- Peripheral Artery Disease
- Coronary Artery Disease
- Renal Artery Disease
- Carotid Artery Disease
- Other Vascular Diseases
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Strategic Insights
Peripheral Stent Market Growth Drivers- Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases such as coronary artery disease and peripheral artery disease is a major driver for the peripheral stent market. As these conditions require stenting procedures for vascular support and blood flow restoration, the demand for peripheral stents continues to grow, especially in aging populations with higher risk factors.
- Technological Advancements in Stent Design: Advances in stent technology, including drug-eluting stents (DES), bioresorbable stents, and improved materials, are propelling the growth of the peripheral stent market. These innovations improve patient outcomes, reduce the risk of restenosis, and enhance the long-term effectiveness of stents, driving their adoption in clinical practice.
- Growing Geriatric Population: The global aging population is contributing to the growing peripheral stent market. Older individuals are more susceptible to peripheral artery disease and other vascular disorders, increasing the need for stent interventions. This demographic trend creates a steady demand for peripheral stents, particularly in developed countries with aging populations.
- Shift Towards Minimally Invasive Procedures: There is a growing trend toward minimally invasive procedures, including the use of peripheral stents, due to their ability to reduce recovery time and complications. Patients and healthcare providers prefer these procedures over traditional open surgeries, fueling the demand for advanced peripheral stents.
- Use of Drug-Eluting Stents (DES): Drug-eluting stents are increasingly popular in the treatment of peripheral artery disease due to their ability to release medication that prevents restenosis. This trend toward DES is driven by their higher efficacy in reducing the risk of stent blockage and improving long-term patient outcomes.
- Rise of Biodegradable Stents: Biodegradable or bioresorbable stents are gaining traction in the peripheral stent market. These stents provide temporary vascular support and gradually dissolve after achieving their therapeutic effect, reducing long-term complications and eliminating the need for further surgical interventions, a trend that is changing the landscape of stent technology.
- Expansion in Emerging Markets: Emerging markets, particularly in Asia-Pacific, Latin America, and Africa, offer significant growth opportunities for the peripheral stent market. Increased healthcare access, improving medical infrastructures, and rising cardiovascular disease rates in these regions drive the demand for peripheral stents, creating new revenue streams for global manufacturers.
- Innovation in Stent Materials: There is a growing opportunity for developing new stent materials, such as flexible alloys, polymers, and composites, that can enhance the performance and reduce complications associated with stents. Manufacturers can capitalize on this opportunity by investing in R&D to create superior stents with better biocompatibility, reduced thrombosis, and fewer adverse reactions.
- Integration with Advanced Imaging Technologies: The integration of peripheral stents with advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provides an opportunity for more accurate placement and monitoring of stents. This collaboration offers potential for improved patient outcomes and precision, driving the adoption of stents in clinical practice.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peripheral Stent Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Peripheral Stent Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors include the rising prevalence of cardiovascular diseases, advancements in stent technologies (e.g., drug-eluting and biodegradable stents), and an aging global population, all contributing to increased demand for peripheral stents.
Key trends include the growing use of drug-eluting stents (DES), the shift toward minimally invasive procedures, and the rise of biodegradable stents, all enhancing patient outcomes and stent performance.
Opportunities lie in expanding access to emerging markets, developing new stent materials, and integrating stents with advanced imaging technologies, which can improve precision and patient outcomes during stent placement.
North America and Europe are expected to dominate the market due to advanced healthcare systems, but emerging markets in Asia-Pacific, Latin America, and Africa offer significant growth opportunities due to improving medical access and rising cardiovascular disease rates.
Drug-eluting stents (DES), biodegradable stents, and self-expanding stents are in high demand due to their efficacy in preventing restenosis, improving long-term outcomes, and offering more biocompatible solutions for vascular conditions.
Challenges include the risk of restenosis (in-stent restenosis), high procedural costs, and the need for continuous innovation in stent materials to reduce complications like thrombosis and vascular injury, which may hinder market growth.
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cordis (A Cardinal Health Company)
- Cook Medical
- Terumo Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- Sorin Group (now LivaNova)
- Cardiovascular Systems, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For